Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
12/29/2005 | US20050288238 Benzocyclodecane derivatives with antitumor activity |
12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
12/29/2005 | CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors |
12/28/2005 | EP1608619A1 Muscarinic agonists |
12/28/2005 | EP1495011B1 A semi-synthetic process for the preparation of n debenzoylpaclitaxel |
12/28/2005 | EP1485057B1 Derivatives of azaspiro compounds for the treatment of pain |
12/28/2005 | EP1049686B9 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
12/28/2005 | EP1002790B1 Sphingosine analogues |
12/28/2005 | CN1714074A Process for producing aromatic nitrile compound |
12/28/2005 | CN1233618C Benzoylcyclohexanone amine compounds with herbicidal activity |
12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
12/22/2005 | WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
12/22/2005 | WO2005113558A3 Simple stereocontrolled synthesis of salinosporamide a |
12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/22/2005 | US20050282876 Inhibitors of IMPDH enzyme |
12/22/2005 | US20050282805 Five-membered heterocycles useful as serine protease inhibitors |
12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
12/22/2005 | US20050282780 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid |
12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
12/22/2005 | CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
12/21/2005 | EP1606351A2 Cyanine dye labelling reagents with meso-substitution |
12/21/2005 | EP1606249A2 Compounds, a process for their preparation and their use as dyes and pigments |
12/21/2005 | CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
12/21/2005 | CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs |
12/21/2005 | CN1711084A Substituted 4-alkoxyoxazol derivatives as PPAR agonists |
12/21/2005 | CN1232511C Process for preparing oxazolyl acetate derivative and its salts |
12/21/2005 | CN1232505C Substituted sulfamide (thio) carbonyl compounds |
12/15/2005 | WO2005118561A1 Benzoxazolone derivatives, processes for preparing them and their uses |
12/15/2005 | WO2005118543A1 Kinase inhibitor and use thereof |
12/15/2005 | WO2005118511A2 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
12/15/2005 | WO2005117817A1 M-phenylene diamine coupler components |
12/15/2005 | WO2005080357A3 Oxazole derivatives, preparation and therapeutic use therof |
12/15/2005 | US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
12/15/2005 | US20050277632 2-Hydroxyethylamines 2-substituted by a hydroxy-N-heterocycle and N-substituted by an omega-phenyl-1,1-dimethylalkyl group: 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-ethyl}-2,2-dimethyl-4H-benzo[1,4]oxazin-3-one; betamimetics |
12/15/2005 | US20050277631 Vanilloid receptor ligands and their use in treatments |
12/15/2005 | DE10210195B4 Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz Using 1,3-diazaspiro [4,5] decane-2,4-dithione for treating pain |
12/15/2005 | DE102004026732A1 m-Phenylendiamin-Kupplerkomponenten m-phenylenediamine coupler components |
12/15/2005 | CA2567909A1 Benzoxazolone derivatives, processes for preparing them and their uses |
12/14/2005 | EP1603905A1 Vanilloid receptor ligands and their use in treatments |
12/14/2005 | EP1603902A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
12/14/2005 | CN1708306A Quinazolinone compounds as calcilytics |
12/14/2005 | CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates |
12/14/2005 | CN1231456C Process for preparing optically active cyclopropyl carboxylic acid derivative |
12/14/2005 | CN1231440C Novel tricyclic compound |
12/13/2005 | US6974875 Animal extracts; anticancer agents |
12/13/2005 | US6974872 Process for production of piperidine derivatives |
12/08/2005 | WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS |
12/08/2005 | WO2005116016A1 Compounds and compositions as ppar modulators |
12/08/2005 | WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
12/08/2005 | WO2005115999A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama |
12/08/2005 | WO2005115998A1 TYROSINE DERIVATIVES SUBSTITUTED BY ALKANOYLAS hPPARα & hPPARϜ ANGONISTS |
12/08/2005 | WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
12/08/2005 | WO2005115148A1 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides |
12/08/2005 | WO2005009951A3 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
12/08/2005 | WO2004056315A8 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
12/08/2005 | US20050272793 Pyrazole compounds and uses related thereto |
12/08/2005 | US20050272786 Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents |
12/08/2005 | US20050272784 Inhibitors of bacterial Type III protein secretion systems |
12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
12/08/2005 | US20050272771 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
12/08/2005 | US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
12/08/2005 | US20050272704 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
12/08/2005 | CA2565257A1 Thioether derivatives, their manufacture and use as pharmaceutical agents |
12/08/2005 | CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
12/08/2005 | CA2563819A1 Compounds and compositions as ppar modulators |
12/07/2005 | EP1601671A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
12/07/2005 | EP1294717B1 A thiazine oxazolidinone |
12/07/2005 | EP1069115B1 Process for producing oxazolidin-2-one derivatives |
12/07/2005 | CN1705668A Heterocyclocarboxamide derivatives |
12/07/2005 | CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
12/07/2005 | CN1230435C Heteroaryl-substd. heterocycles |
12/07/2005 | CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
12/06/2005 | US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells |
12/06/2005 | US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
12/06/2005 | CA2160081C Manufacture of 4-aryl-2-perfluoroalkyl-3-oxazolin-5-one from arylglycine |
12/01/2005 | WO2005113558A2 Simple stereocontrolled synthesis of salinosporamide a |
12/01/2005 | WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase |
12/01/2005 | WO2005113523A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
12/01/2005 | WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems |
12/01/2005 | WO2005113521A1 Process of preparing substituted carbamates and intermediates thereof |
12/01/2005 | WO2005113520A1 Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents |
12/01/2005 | WO2005113490A1 Sulfone-containing prodrugs |
12/01/2005 | WO2005112945A2 Synthesis of tetracyclines and analogues thereof |
12/01/2005 | WO2005112913A1 Transthyretin stabilization |
12/01/2005 | WO2005060456A3 Method for treating adamts-5-associate disease |
12/01/2005 | US20050267180 treatment/prevention of non-insulin dependent diabetes mellitus, lowing cholesterol, decrease blood pressure, counteract inflammatory atherosclerosis, metabolic disorders, polycystic ovary syndrome, liver disorders; S)-2-Ethoxy-3-[2-methyl-4-(5-methyl-2-o-tolyl-oxazol-4-ylmethoxy)-phenyl]-propionic acid |
12/01/2005 | US20050267177 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals |
12/01/2005 | US20050267163 Vanilloid receptor ligands and their use in treatments |
12/01/2005 | US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
12/01/2005 | US20050267032 Sulfone-containing prodrugs |
12/01/2005 | CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase |
12/01/2005 | CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
12/01/2005 | CA2566688A1 Transthyretin stabilization |
11/30/2005 | EP1599455A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
11/30/2005 | EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
11/30/2005 | EP1599453A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |